This would effectively end Hurts’ season, as a three-month absence would have him on track to return some time in late-January/early-February. In a statement released by Hurts’ agent, Nicole Lyyn, she said further tests revealed “deep vein thrombosis as well as bilateral pulmonary emboli.” She said that Hurts is stable and is not expected to have any “functional limitations” and that his treatment to resolve his blood clotting issues “should only involve anticoagulation [i.e., ‘blood thinners’].” As a result, Hurts will not be permitted to engage in football activities and will not be allowed to resume them until he is off his blood thinners. The good news here is that Hurts is expected to make a full recovery, and the doctors do not believe this will have a long-term effect on him moving forward. Hurts threw for 933 yards, eight touchdowns, and three interceptions this season while completing 57.8 percent of his passes — his lowest mark since his rookie season. He ran for another 107 yards and one touchdown as he and the Eagles struggled in his first five starts under offensive coordinator Sean Mannion. He remains under contract through the 2028 season, but Hurts has faced his fair share of scrutiny since leading the Eagles to a Super Bowl title in 2024. Hurts’ contract situation would suggest his job is more than secured for the foreseeable future, but this is the same Eagles front office that used a 2020 second round pick to select him as the heir apparent to Carson Wentz, who signed a four-year extension with the team in 2019. While we fully expect Hurts to be back with the Eagles next season, we can’t rule out the team using an early draft pick on a quarterback in a draft that is projected to be one of the more QB-rich drafts in recent memory.